Business
FUNR to Disrupt Telemedicine with “FUNRx AI Platform” – A New Era of Smarter, Predictive and High-Quality Healthcare
FUNR to Disrupt Telemedicine with “FUNRx AI Platform” – A New Era of Smarter, Predictive and High-Quality Healthcare.
About this update from Funr
[{"type":"text","content":"La Jolla, California – June 26, 2025 – FUNR (the\r\nCompany) (OTCPK: FUNR) is on the brink\r\nof revolutionizing telemedicine with the launch of its next-gen \"FUNRx\r\nPlatform\", a bold fusion of cutting-edge telemedicine, artificial\r\nintelligence, and in-house pharmaceutical production. The Company has finalized\r\na Strategic Revenue Share and Equity Partnership with Nutra Custom Corp.,\r\npositioning FUNR to lead the future of healthcare delivery.\r\nThis game-changing partnership will combine telemedicine\r\nservices with advanced pharmaceutical manufacturing, creating a disruptive\r\nplatform that offers unmatched convenience, predictive care, and superior\r\nquality. FUNRx isn’t just a service – it's a new standard in how healthcare is\r\ndelivered, offering personalized, proactive care that anticipates patient needs\r\nbefore they arise.\r\nUnder the leadership of CEO Ethan Zachadnyk, FUNR is\r\nreimagining patient care, blending licensed medical professionals with\r\ncutting-edge AI to deliver smarter, faster and more effective healthcare. This\r\nis more than just telemedicine; it's the future of a holistic healthcare ecosystem\r\ndesigned to deliver long-term value and change the lives of patients.\r\n“With FUNRx, we’re not just offering telemedicine, we’re\r\nsetting a new benchmark for the entire healthcare industry,” said CEO Ethan\r\nZachadnyk. “This platform will give patients access to smarter, more\r\npersonalized care, while creating significant value for our shareholders.”\r\n“We are thrilled to partner with FUNR and be part of this\r\ntransformative shift in healthcare,” said Dr. Mark Forster, CEO and Founder of\r\nNutra Custom. “This collaboration merges our expertise in pharmaceutical\r\nproduction with their innovative telemedicine platform, and together, we’re\r\npoised to redefine the future of personalized, predictive healthcare.”\r\nCAUTIONARY\r\nDISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS This release contains\r\nforward-looking statements within the meaning of Section 27A of the Securities\r\nAct of 1933, as amended, and Section 21E the Securities Exchange Act of 1934,\r\nas amended and such forward-looking statements are made pursuant to the safe\r\nharbor provisions of the Private Securities Litigation Reform Act of 1995.\r\nStatements in this news release other than statements of histori...